| Product Code: ETC13162028 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Psychedelic Drugs Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Psychedelic Drugs Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Psychedelic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 North America Psychedelic Drugs Market - Industry Life Cycle |
3.4 North America Psychedelic Drugs Market - Porter's Five Forces |
3.5 North America Psychedelic Drugs Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Psychedelic Drugs Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 North America Psychedelic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 North America Psychedelic Drugs Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.9 North America Psychedelic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 North America Psychedelic Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.11 North America Psychedelic Drugs Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 North America Psychedelic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Psychedelic Drugs Market Trends |
6 North America Psychedelic Drugs Market, 2021 - 2031 |
6.1 North America Psychedelic Drugs Market, Revenues & Volume, By Source, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Psychedelic Drugs Market, Revenues & Volume, By Synthetic, 2021 - 2031 |
6.1.3 North America Psychedelic Drugs Market, Revenues & Volume, By Natural, 2021 - 2031 |
6.2 North America Psychedelic Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Psychedelic Drugs Market, Revenues & Volume, By Empathogens, 2021 - 2031 |
6.2.3 North America Psychedelic Drugs Market, Revenues & Volume, By Dissociatives, 2021 - 2031 |
6.3 North America Psychedelic Drugs Market, Revenues & Volume, By Drugs, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Psychedelic Drugs Market, Revenues & Volume, By Gamma-Hydroxybutyric Acid, 2021 - 2031 |
6.3.3 North America Psychedelic Drugs Market, Revenues & Volume, By Ketamine, 2021 - 2031 |
6.3.4 North America Psychedelic Drugs Market, Revenues & Volume, By Psilocybin, 2021 - 2031 |
6.4 North America Psychedelic Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 North America Psychedelic Drugs Market, Revenues & Volume, By Treatment Resistant Depression, 2021 - 2031 |
6.4.3 North America Psychedelic Drugs Market, Revenues & Volume, By Major Depressive Disorder, 2021 - 2031 |
6.4.4 North America Psychedelic Drugs Market, Revenues & Volume, By Opiate Addiction, 2021 - 2031 |
6.4.5 North America Psychedelic Drugs Market, Revenues & Volume, By Post-Traumatic Stress Disorder, 2021 - 2031 |
6.5 North America Psychedelic Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 North America Psychedelic Drugs Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.5.3 North America Psychedelic Drugs Market, Revenues & Volume, By Inhalation, 2021 - 2031 |
6.5.4 North America Psychedelic Drugs Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.6 North America Psychedelic Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 North America Psychedelic Drugs Market, Revenues & Volume, By Hospital, 2021 - 2031 |
6.6.3 North America Psychedelic Drugs Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.6.4 North America Psychedelic Drugs Market, Revenues & Volume, By Homecare, 2021 - 2031 |
7 North America Psychedelic Drugs Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Psychedelic Drugs Market, Revenues & Volume, By Source, 2021 - 2031 |
7.2.1 United States (US) Psychedelic Drugs Market, Revenues & Volume, By Source, 2021 - 2031 |
7.2.2 Canada Psychedelic Drugs Market, Revenues & Volume, By Source, 2021 - 2031 |
7.2.3 Rest of North America Psychedelic Drugs Market, Revenues & Volume, By Source, 2021 - 2031 |
7.3 North America Psychedelic Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
7.3.1 United States (US) Psychedelic Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.2 Canada Psychedelic Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.3 Rest of North America Psychedelic Drugs Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Psychedelic Drugs Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4.1 United States (US) Psychedelic Drugs Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4.2 Canada Psychedelic Drugs Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.4.3 Rest of North America Psychedelic Drugs Market, Revenues & Volume, By Drugs, 2021 - 2031 |
7.5 North America Psychedelic Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.1 United States (US) Psychedelic Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.2 Canada Psychedelic Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5.3 Rest of North America Psychedelic Drugs Market, Revenues & Volume, By Application, 2021 - 2031 |
7.6 North America Psychedelic Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6.1 United States (US) Psychedelic Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6.2 Canada Psychedelic Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6.3 Rest of North America Psychedelic Drugs Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Psychedelic Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7.1 United States (US) Psychedelic Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7.2 Canada Psychedelic Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
7.7.3 Rest of North America Psychedelic Drugs Market, Revenues & Volume, By End User, 2021 - 2031 |
8 North America Psychedelic Drugs Market Key Performance Indicators |
9 North America Psychedelic Drugs Market - Export/Import By Countries Assessment |
10 North America Psychedelic Drugs Market - Opportunity Assessment |
10.1 North America Psychedelic Drugs Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Psychedelic Drugs Market Opportunity Assessment, By Source, 2021 & 2031F |
10.3 North America Psychedelic Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
10.4 North America Psychedelic Drugs Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10.5 North America Psychedelic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10.6 North America Psychedelic Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.7 North America Psychedelic Drugs Market Opportunity Assessment, By End User, 2021 & 2031F |
11 North America Psychedelic Drugs Market - Competitive Landscape |
11.1 North America Psychedelic Drugs Market Revenue Share, By Companies, 2022 |
11.2 North America Psychedelic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here